{
    "2020-03-20": [
        [
            {
                "time": "",
                "original_text": "华大基因股东拟减持不超过1%股份 拟减持股份",
                "features": {
                    "keywords": [
                        "华大基因",
                        "股东",
                        "减持",
                        "1%股份"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "华大基因：股东拟减持公司不超过1%股权 拟减持股份",
                "features": {
                    "keywords": [
                        "华大基因",
                        "股东",
                        "减持",
                        "1%股权"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "华大基因：和玉高林和高林同创拟减持不超过总股本1%",
                "features": {
                    "keywords": [
                        "华大基因",
                        "和玉高林",
                        "高林同创",
                        "减持",
                        "总股本1%"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "[互动]华大基因：已累积生产超过200万人份新冠病毒核酸检测试剂盒",
                "features": {
                    "keywords": [
                        "华大基因",
                        "新冠病毒",
                        "核酸检测",
                        "试剂盒",
                        "200万人份"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技",
                        "医疗设备"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}